Clinical event adjudication in cardiovascular device trials: An Food and Drug Administration perspective
- PMID: 28888271
- DOI: 10.1016/j.ahj.2017.05.010
Clinical event adjudication in cardiovascular device trials: An Food and Drug Administration perspective
Comment on
-
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium.Am Heart J. 2017 Aug;190:76-85. doi: 10.1016/j.ahj.2017.05.009. Epub 2017 May 28. Am Heart J. 2017. PMID: 28760216 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
